---
title: New Report Highlights Risks of U.S. Drug Reimportation
description: New Report Highlights Risks of U.S. Drug Reimportation
---

[News ](https://www.yourway.com/news)

# [New Report Highlights Risks of U.S. Drug Reimportation](https://www.yourway.com/news/new-report-highlights-risks-of-u.s.-drug-reimportation)

 Written by [Yourway](https://www.yourway.com/news/author/yourway) | September 6, 2019

While the reimportation of drugs into the U.S. from abroad is a popular topic among politicians and advocates looking for ways to reduce domestic healthcare costs, the research arm of the Healthcare Distribution Alliance has released a new [report](https://hda.org/resources/the-risks-and-realities-of-commercial-drug-importation) highlighting some little-discussed costs and risks associated with reimportation. Yourway is no stranger to logistical challenges and is monitoring this issue.

[View full post](https://www.yourway.com/news/new-report-highlights-risks-of-u.s.-drug-reimportation)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Yourway"
  },
  "dateModified" : "2019-09-03T20:50:01.140Z",
  "datePublished" : "2019-09-06T12:00:00Z",
  "headline" : "New Report Highlights Risks of U.S. Drug Reimportation",
  "image" : {
    "@type" : "ImageObject",
    "height" : 971,
    "url" : "https://cdn2.hubspot.net/hubfs/5402331/News%20and%20Articles%20Banners/iStock-182697393.jpg",
    "width" : 1400
  },
  "mainEntityOfPage" : "https://www.yourway.com/news/new-report-highlights-risks-of-u.s.-drug-reimportation",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "News"
  }
}
```